1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Let's do Santarus Act 2!

Discussion in 'Santarus' started by Anonymous, Apr 27, 2015 at 4:59 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I wake up everyday just hoping we can do it again with Gerry and the gang. (Then I count my stock money and realize I'm so fortunate it happened once, even if there isn't a second act).
     

  2. Anonymous

    Anonymous Guest

    Can't wait for San Diego next month! I'm really hoping Gerry announces he is starting another company. I would give my notice to Valeant on the spot! He is on the board of 3 companies that have developmental products and no sales force?!
     
  3. Anonymous

    Anonymous Guest

    That would be awesome!